Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

People of African-Caribbean heritage living with diabetes have greater kidney disease risk

New research confirms for the first time that ethnicity is a risk factor for developing kidney disease in people with Type 1 diabetes.

1 Sep 2022

Tight control of blood sugar in teens may help reduce diabetes-related brain damage

Tight control of blood sugar in teens with Type 1 diabetes may help reduce the disease's damaging effects on the brain, effects which have been shown even in younger children, according to a study published online today in Nature Communications.

30 Aug 2022

Severe COVID-19 increases risk of future cardiovascular events

A recent study determines the relationship between COVID-19 severity and risk of subsequent cardiovascular events in a large cohort.

24 Aug 2022

Incidence of type 2 diabetes in youth increased during COVID-19 pandemic

A new study assesses the impact of the COVID-19 pandemic on the onset of T2D among the youth.

22 Aug 2022

“Drug factory” implants show promise in eradicating mesothelioma tumors

Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and a checkpoint inhibitor drug.

22 Aug 2022

Serious health events rare in children after COVID-19 vaccine booster, says CDC study

Researchers published the effects of a homologous booster dose of the BNT162b2 COVID-19 vaccine in children aged five to 11 years.

22 Aug 2022

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

A recent article illustrated the derivation and validation of the QCOVID4 risk determination algorithm for predicting COVID-19 hospitalization and death risk in England.

18 Aug 2022

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.

17 Aug 2022

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

In a new study, researchers assessed the incidence of post-COVID-19 symptoms and conditions among children and adolescents.

9 Aug 2022

Implantable mechanotherapeutic drug delivery platform helps overcome host immune response

Implantable devices that release insulin into the body hold promise as an alternative way to treat diabetes without insulin injections or cannula insertions. However, one obstacle that has prevented their use so far is that the immune system attacks them after implantation, forming a thick layer of scar tissue that blocks insulin release.

8 Aug 2022

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

In a potential game changer for patients with type 2 diabetes, a team of researchers at the Diabetes, Obesity, and Metabolism Institute (DOMI) at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells) - cells in the pancreas that produce and distribute insulin.

4 Aug 2022

Study: Children with type 1 diabetes and their family members are at increased risk of mental health problems

Both children with type 1 diabetes and their closest family members are at increased risk of mental health problems compared with those without the disease, according to a large study by researchers at Karolinska Institutet in Sweden published in the journal Diabetes Care.

1 Aug 2022

Higher insulin dose is positively linked with cancer incidence, study finds

Dr. Yuanjie Mao has led a study published in the Journal of the American Medical Association (JAMA) Oncology looking at the correlation between daily insulin dose and cancer incidence (the number of new cases) among patients with type 1 diabetes, finding that higher insulin dose is positively associated with cancer incidence and that the association is stronger among those with insulin resistance.

29 Jul 2022

Icelandic study reveals how many children experience severe COVID symptoms

Researchers explore the incidence of SARS-CoV-2 infections in Icelandic children.

27 Jul 2022

A major breakthrough toward new treatments for Type 1 and Type 2 diabetes

A world-first study by Monash University, in Melbourne, Australia has discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes.

22 Jul 2022

Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabetics

People with a severe form of diabetes, where the beta cells of the pancreas do not produce or no longer produce enough insulin, have no choice but to inject themselves regularly with artificial insulin in order to survive.

18 Jul 2022

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.

14 Jul 2022

Researchers may be one step closer to preventing Type 1 diabetes

Australian researchers may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold.

14 Jul 2022

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

In a new study, researchers reported that Pfizer’s BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 does not affect the honeymoon phase of type 1 diabetes (T1D).

13 Jul 2022

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system's history with other coronaviruses, including those behind the common cold, shapes the patient's response, according to a study published today in Cell Reports.

6 Jul 2022

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

People of African-Caribbean heritage living with diabetes have greater kidney disease risk

Tight control of blood sugar in teens may help reduce diabetes-related brain damage

Severe COVID-19 increases risk of future cardiovascular events

Incidence of type 2 diabetes in youth increased during COVID-19 pandemic

“Drug factory” implants show promise in eradicating mesothelioma tumors

Serious health events rare in children after COVID-19 vaccine booster, says CDC study

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

Implantable mechanotherapeutic drug delivery platform helps overcome host immune response

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

Study: Children with type 1 diabetes and their family members are at increased risk of mental health problems

Higher insulin dose is positively linked with cancer incidence, study finds

Icelandic study reveals how many children experience severe COVID symptoms

A major breakthrough toward new treatments for Type 1 and Type 2 diabetes

Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabetics

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Researchers may be one step closer to preventing Type 1 diabetes

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Newsletters you may be interested in